October University for Modern Sciences and Arts Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT03716765
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

October University for Modern Sciences and Arts | october university of modern sciences and arts

Active Ingredients

Drugs in Other Trials (2)

onabotulinumtoxinA (Botox) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 2